Skip to main content Skip to main navigation
Government logo | to homepage of Loket Gentherapie National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • EN
  • NL
  • Home
  • Gene Therapy Office
    • History
    • Overview of assessment bodies
    • Assessment procedures
    • Tips for the applicant
  • Preliminary consult
    • Assessment frameworks
    • Preparation by the investigator
    • Organisation
  • Application form
    • Part A: Biosafety aspects
    • Part B: Patient-related aspects
  • Ongoing study
    • What to do in the event of changes to the research
    • What to do in the event of adverse events and unexpected circumstances
    • Periodic reports and notifications
  • Links
  • FAQ
  • Home
  • What to do in the event of changes to the research

What to do in the event of changes to the research

Modifications to ongoing gene therapy research will need to be submitted with conditions.

Wijzigingen CCMO / substantiële amendementen

Wijzigingen CCMO Centrale Commissie Mensgebonden Onderzoek (Centrale Commissie Mensgebonden Onderzoek ) / substantiële amendementen
( /en/node/941 )

Wijzigingen IenW

Wijzigingen IenW
( /en/node/961 )
Medicijnen

Share this page

  • Facebook (link is external)
  • X (link is external)
  • LinkedIn (link is external)
  • WhatsApp (link is external) (opens in a new window)
  • Email

Service

  • Contact
  • RIVM.nl (link is external)
  • Archive

About this site

  • Sitemap
  • Cookies
  • Toegankelijkheid
  • Proclaimer
  • Responsible disclosure
  • Privacy (link is external)